SEC Form 3 · accession 0000947871-16-001005
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share ("Common Stock")F1 | holding | — | — | — | 8,888 | D | ||
| Common StockF1 | holding | — | — | — | 8,888 | I | Through Dragon Alpha LP | |
| Common StockF1 | holding | — | — | — | 8,888 | I | Through Dragon Alpha LP and Jade Park Investments Limited |
Table II — derivative securities
Explanation of responses
- F18,888 shares of Common Stock are owned directly by Dragon Alpha LP ("Dragon Alpha"). Jade Park Investments Limited ("Jade Park") is the general partner of Dragon Alpha. Jade Park is wholly-owned by Mr. Lanchu Liu ("Mr. Liu").
Remarks
In connection with the announcement made by the Issuer on February 4, 2016 regarding initiating a process (the "Process") to identify, examine and consider a range of strategic alternatives available to the Issuer, Jade Park, GL Capital Management GP Limited, Bank of China Group Investment Limited and ABG Management Limited (collectively, the "Sponsors") entered into a consortium agreement, pursuant to which the Sponsors agreed to cooperate and proceed in good faith to participate in the Process and/or the transaction contemplated under the Process. Pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934, Dragon Alpha, Jade Park, Mr. Liu and the other Sponsors and certain of their respective affiliates may, based on the facts described in this paragraph, be considered to be a "group", but each of Dragon Alpha, Jade Park and Mr. Liu individually owns less than 10% of the shares of Common Stock of the Issuer and other members of the group do not have a pecuniary interest in any shares of Common Stock owned by Dragon Alpha, Jade Park and Mr. Liu.